Morningstar (MORN) PT Lowered to $320 at UBS
Tweet
Share
E-mailGet Alerts MORN Hot Sheet
Price: $217.49 +1.80%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS analyst Alex Kramm lowered the price target on Morningstar (NASDAQ: MORN) to $320.00 (from $350.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Marti Technologies (MRT) PT Lowered to $3.50 at Roth/MKM
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
